Current and future alternatives to surgical neutering in ferrets to prevent hyperadrenocorticism

Veterinary Medicine

Volumn 100, Issue 7, 2005, Pages 484-496

  Schoemaker, Nico J ^a   Lumeij, Johannes T ^a   Rijnberk, Ad ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MUSTELA; MUSTELA PUTORIUS FURO;

EID: 23744454620     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Bernard SL, Leathers CW, Brobst DF, et al. Estrogen-induced bone marrow depression in ferrets. Am J Vet Res 1983;44:657-661.
2. Kociba GJ, Caputo CA. Aplastic anemia associated with estrus in pet ferrets. J Am Vet Med Assoc 1981;178:1293-1294.
3. Mullen H. Soft tissue surgery. In: Hillyer EV, Quesenberry KE, eds. Ferrets, rabbits, and rodents: clinical medicine and surgery. Philadelphia, Pa: WB Saunders, 1996;131-144.
4. Rosenthal KL, Peterson ME, Quesenberry KE, et al. Hyperadrenocorticism associated with adrenocortical tumor or nodular hyperplasia of the adrenal gland in ferrets: 50 cases (1987-1991). J Am Vet Med Assoc 1993;203:271-275.
5. Rosenthal KL, Peterson ME. Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism. J Am Vet Med Assoc 1996;209:1097-1102.
6. Schoemaker NJ, Schuurmans M, Moorman H, et al. Correlation between age at neutering and age at onset of hyperadrenocorticism in ferrets. J Am Vet Med Assoc 2000;216:195-197.
7. Weiss CA, Scott MV. Clinical aspects and surgical treatment of hyperadrenocorticism in the domestic ferret: 94 cases (1994-1996). J Am Anim Hosp Assoc 1997;33:487-493.
8. Rosenthal KL. Adrenal gland disease in ferrets. Vet Clin North Am Small Anim Pract 1997;27:401-418.
9. Eatwell K. Two unusual tumours in a ferret (Mustela putorius furo). J Small Anim Pract 2004;45:454-459.
10. Lloyd M. Endocrine diseases. In: Ferrets: health, husbandry and diseases. Oxford, UK: Blackwell Science, 1999;67-77.
11. Wagner RA, Bailey EM, Schneider JF, et al. Leuprolide acetate treatment of adrenocortical disease in ferrets. J Am Vet Med Assoc 2001;218:1272-1274.
12. Schoemaker NJ, Teerds KJ, Mol JA, et al. The role of luteinizing hormone in the pathogenesis of hyperadrenocorticism in neutered ferrets. Mol Cell Endocrinol 2002;197:117-125.
13. Hart DS. Photoperiodicity in the female ferret. J Exp Biol 1951;28:1-12.
14. Herbert J. The pineal gland and light-induced oestrus in ferrets. J Endocrinol 1969;43:625-636.
15. Baum MJ, Lynch HJ, Gallagher CA, et al. Plasma and pineal melatonin levels in female ferrets housed under long or short photoperiods. Biol Reprod 1986;34:96-100.
16. Concise veterinary dictionary. Oxford, UK: Oxford University Press, 1988.
17. Webster's new collegiate dictionary. Springfield, Mass: G&C Merriam Co, 1974.
18. Hasegawa A, Hamada Y, Shigeta M, et al. Contraceptive potential of synthetic peptides of zona pellucida protein (ZPA). J Reprod Immunol 2002;53:91-98; 2002.
19. Primakoff P, Lathrop W, Woolman L, et al. Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20. Nature 1988;335:543-546.
20. Concannon PW, Meyers-Wallen VN. Current and proposed methods for contraception and termination of pregnancy in dogs and cats. J Am Vet Med Assoc 1991;198:1214-1225.
21. Kluth GA. Oestrus control in ferrets. Vet Rec 1993;133:252.
22. Oxenham M. Oestrus control in the ferret. Vet Rec 1990;126:148.
23. Fox JG, Pearson RC, Bell JA. Diseases of the genitourinary system. In: Fox JG, ed. Biology and diseases of the ferret. 2nd ed. Baltimore, Md: Williams & Wilkins, 1998;247-272.
24. Schaefers-Okkens AC. Ovaries. In: Rijnberk A, ed. Clinical endocrinology of dogs and cats; an illustrated text. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1996;131-156.
25. Grossman LS, Martis B, Fichtner CG. Are sex offenders treatable? A research overview. Psychiatr Serv 1999;50:349-361.
26. Meriggiola MC, Costantino A, Cerpolini S. Recent advances in hormonal male contraception. Contraception 2002;65:269-272.
27. Taha MB, Noakes DE, Allen WE. The effect of some exogenous hormones on seminal characteristics, libido and peripheral plasma testosterone concentrations in the male beagle. J Small Anim Pract 1981;22:587-595.
28. Lange K, Cordes EK, Hoppen HO, et al. Determination of concentrations of sex steroids in blood plasma and semen of male dogs treated with delmadinone acetate or finasteride. J Reprod Fert Suppl 2001;57:83-91.
29. Mol JA, van Garderen E, Selman PJ, et al. Growth hormone mRNA in mammary gland tumors of dogs and cats. J Clin Invest 1995;95:2028-2034.
30. Harcourt-Brown F. Biological characteristics of the domestic rabbit (Oryctolagus cuniculi). In: Textbook of rabbit medicine. Oxford, UK: Butterworth-Heinemann, 2002:1-18.
31. Bibeau CE, Tobet SA, Anthony ELP, et al. Vaginocervical stimulation of ferrets induces release of luteinizing hormone-releasing hormone. J Neuroendocrinol 1991;3:29-36.
32. Ryland LM, Lipinski E. A technique for vasectomizing male ferrets. Canine Pract 1994;19:25-27.
33. Carter DS, Herbert J, Stacey PM. Modulation of gonadal activity by timed injections of melatonin in pinealectomized or intact ferrets kept under two photoperiods. J Endocrinol 1982;93:211-222.
34. Herbert J, Stacey PM, Thorpe DH. Recurrent breeding seasons in pinealectomized or optic-nerve-sectioned ferrets. J Endocrinol 1978;78:389-397.
35. Gonzalez A, Allen AF, Post K, et al. Immunological approaches to contraception in dogs. J Reprod Fertil Suppl 1989;39:189-198.
36. Ladd A, Tsong YY, Lok J, et al. Active immunization against LHRH: I. Effects of conjugation site and dose. Am J Reprod Immunol 1990;22:56-63.
37. Meloen RH, Turkstra JA, Lankhof H, et al. Efficient immunocastration of male piglets by immunoneutralization of GnRH using a new GnRH-like peptide. Vaccine 1994;12:741-746.
38. Zeng W, Ghosh S, Lau YF, et al. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. J Immunol 2002;169:4905-4912.
39. Faulkner LC, Pineda MH, Reimers TJ. Immunization against gonadotropins in dogs. In: Neischlag E, ed. Immunization with hormones in reproduction research. Amsterdam, The Netherlands: North Holland Publishing, 1975;199-214.
40. Jeyakumar M, Suresh R, Krishnamurthy HN, et al. Changes in testicular function following specific deprivation of LH in the adult male rabbit. J Endocrinol 1995;147:111-120.
41. Roberts AJ, Reeves JJ. Reproductive and endocrine changes in ewes actively immunized against luteinizing hormone. J Reprod Immunol 1989;16:187-197.
42. Lunnen JE, Faulkner LC, Hopwood ML, et al. Immunization of dogs with bovine luteinizing hormone. Biol Reprod 1974;10:453-460.
43. Saxena BB, Clavio A, Singh M, et al. Modulation of ovarian function in female dogs immunized with bovine luteinizing hormone receptor. Reprod Domest Anim 2002;37:9-17.
44. Remy JJ, Couture L, Rabesona H, et al. Immunization against exon 1 decapeptides from the lutropin/choriogonadotropin receptor or the follitropin receptor as potential male contraceptive. J Reprod Immunol 1996;32:37-54.
45. Vickery BH, McRae GI, Goodpasture JC, et al. Use of potent LHRH analogues for chronic contraception and pregnancy termination in dogs. J Reprod Fertil Suppl 1989;39:175-187.
46. Huirne JAF, Lambalk CB. Gonadotropin-releasing-hormone-receptor antagonists. Lancet 2001;358:1793-1803.
47. Trigg TE, Wright PJ, Armour AF, et al. Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. J Reprod Fertil Suppl 2001;57:255-261.
48. Proháczik A, Kulcsar M, Trigg T, et al. Treatments suppressing ovarian activity in ferret (Mustela putorius furo) (abst). Reprod Domest Anim 2003;38:331.
49. Inaba T, Tani H, Gonda M, et al. Induction of fertile estrus in bitches using a sustained-release formulation of a GnRH agonist (leuprolide acetate). Theriogenology 1998;49:975-982.
50. Millar RP, Zhu YF, Chen C, et al. Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications. Br Med Bull 2000;56:761-772.
51. Broqua P, Riviere PJ, Conn PM, et al. Pharmacological profile of a new, potent, and long-acting gonadotrophin-releasing hormone antagonist: degarelix. J Pharmacol Exp Ther 2002;301:95-102.